Liposic (Carbomer)

Carbomer is a cross‑linked polyacrylic acid polymer that absorbs water and forms a gel matrix. This matrix raises the viscosity of the ophthalmic preparation, creating a thicker layer on the eye that slows drainage and allows the active ingredient to remain in contact with the eye longer.

The dose of Liposic is determined by the prescribing clinician based on the specific ophthalmic product in which it is formulated. The prescriber decides the appropriate volume and frequency of administration for each patient, taking into account the therapeutic indication and the accompanying active drug.

Carbomer is generally considered to have low systemic absorption when applied to the eye. However, safety data specific to pregnancy and lactation are limited. Healthcare professionals should evaluate the risk‑benefit profile for each patient and may choose to avoid use if safer alternatives are available.

To place an order, submit an enquiry on the Liposic product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Carbomer offers a high degree of viscosity control and clear gel formation, which many alternatives such as hyaluronic acid or methylcellulose may not provide. It is chemically stable, compatible with a wide range of active ingredients, and does not typically interfere with drug efficacy, making it a preferred choice for many ophthalmic formulations.

Liposic should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Ensure the container is tightly sealed to maintain gel integrity and prevent contamination.

Liposic is administered as part of an ophthalmic preparation. The clinician or patient instills the prescribed number of drops onto the conjunctival sac, typically using a sterile dropper. The gel’s increased viscosity helps keep the medication in place, reducing the need for frequent dosing.

Serious risks, though rare, include allergic contact dermatitis, corneal ulceration, severe eye pain, and vision loss. Patients should be instructed to seek immediate medical attention if they experience persistent redness, pain, decreased vision, or any signs of an allergic reaction after using the product.

Individuals with a known hypersensitivity to carbomer or any component of the formulation should avoid Liposic. Additionally, patients with active corneal infections or severe ocular surface disease should consult an eye care professional before using products containing carbomer.